Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Anselm Morell (Valencia, Spain), Anselm Morell, Estefania Bel, Javier Milara, Esteban Morcillo, Julio Cortijo. LATE-BREAKING ABSTRACT: MUC1 downregulation induces corticosteroid resistance in asthma’s in vitro and in vivo models. Eur Respir J 2016; 48: Suppl. 60, 4537

Member's Comments

No comment yet.

Related content which might interest you: IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Synergistic suppression of T cell-induced eosinophilia by CTLA4-Ig and glucocorticoid in murine asthma model Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Characterization of an endogenous Th17-cell generation during sensitization in the murine lung Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Aquaporin-3 potentiates murine asthma through mediating T-cell trafficking and chemokine production Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 The effects of clinically relevant reference agents in a mouse model of severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 A murine ovalbumin model exhibits molecular features of steroid insensitive human asthma Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 LATE-BREAKING ABSTRACT: Triptolide modulates the CD4+ T cells balance in an allergic asthmatic mouse model Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Induction of granulocyte apoptosis by Bcl-2 inhibitors reduces steroid-insensitive airway inflammation Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 Alpha-7 nicotinic receptor stimulation reduces airway inflammation in a murine model of asthma Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Rapamycin protects OVA induced asthma in mice through regulating autophagy Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 The effect of anti-IL-33 antibody and soluble ST2 in a murine model of allergic asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 LATE-BREAKING ABSTRACT: The effects of NKT cells on the different degrees of severity bronchial asthma in mice Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Resveratrol upregalates PTEN and inhibits MUC5AC expression in ovalbumin (OVA)-induced asthma model mice Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 The combination of TNF-α neutralization and dexamethasone treatment restored the corticosteroid responsiveness in tobacco smoking mice Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Immunomodulatory role of IL-37 in asthma pathogenesis Source: International Congress 2016 – Immune responses in the lung Year: 2016